## Abstract The new disaccharide anthracycline MEN 10755 induces activation of both NF‐κB and p53 transcription factors in A2780 cells. Nevertheless, pharmacologic inhibition of NF‐κB activation does not modify the sensitivity of A2780 cells to MEN 10755 treatment. To better characterize the role o
A Jurkat transcriptional reporter cell line for high-throughput analysis of the Nuclear Factor-κB signaling pathway
✍ Scribed by Amanda M. Gonzales; Robert A. Orlando
- Publisher
- Elsevier
- Year
- 2009
- Tongue
- English
- Weight
- 400 KB
- Volume
- 26
- Category
- Article
- ISSN
- 1871-6784
No coin nor oath required. For personal study only.
✦ Synopsis
The transcription factor, Nuclear Factor-kappaB (NF-kappaB), regulates many genes involved in host immunity and cell survival. Unregulated NF-kappaB activity has been linked to many chronic inflammatory diseases and is an important target for the identification of inhibitors to better manage these disorders. We present a novel screening system to identify NF-kappaB inhibitors that combines sensitive fluorescence detection with medium- to high-throughput flow cytometry (HyperCyt). To validate this approach, we quantified the activation of NF-kappaB by standard flow cytometry and the HyperCyt platform. Results were comparable with regard to EC(50) values for TNFalpha-mediated activation; however, the HyperCyt platform provided more sensitive signal detection and a greater linear range for detection. To demonstrate the usefulness of this screening tool, we identified a novel inhibitor of NF-kappaB activation from a resveratrol-based chemical library. The inhibition of NF-kappaB activation by analog 6q (IC(50) = 19 microm) showed a 3.7-fold improvement over that of resveratrol (IC(50) approximately 70 microm).
📜 SIMILAR VOLUMES